Boothbay Fund Management, LLC Poly Pid Ltd. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.34 - $0.45 $340 - $450	-1,000 Reduced 0.81%	121,898 $43,000
Q1 2023 May 15, 2023	BUY	$0.4 - $1.08 $41,159 - $111,129	102,898 Added 514.49%	122,898 $56,000
Q4 2022 Feb 14, 2023	BUY	$0.66 - $38.7 $3,300 - $193,500	5,000 Added 33.33%	20,000 $14,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $36.9 $15,900 - $553,500	15,000 New	15,000 $18,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $69.6M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.